Airway Therapeutics

We envision a future where our immune-modulating therapies fundamentally change how we prevent and treat respiratory, inflammatory, and infectious diseases. Through our first-in-class biologic, zelpultide alfa, we aim to break the destructive cycle of dysregulated inflammation and infection by modulating immune responses at the source. Guided by science, we are building a platform that helps patients breathe easier, recover faster, and live longer, healthier lives, driving a global shift in t...

Total raised: $18M